menu search

Jazz pharmaceuticals begins enrollment for clinical trial to evaluate jzp150 for adults with ptsd

Biopharmaceutical company Jazz Pharmaceuticals plc (NASDAQ: JAZZ) announced Thursday that it has enrolled the first patient in its Phase 2 clinical tr...

December 30, 2021, 1:11 pm

Jazz pharmaceuticals begins enrollment for clinical trial to evaluate jzp150 for adults with ptsd

Biopharmaceutical company Jazz Pharmaceuticals plc (NASDAQ: JAZZ) announced Thursday that it has enrolled the first patient in its Phase 2 clinical tr...

December 30, 2021, 1:11 pm

Jazz pharmaceuticals begins enrollment for clinical trial to evaluate jzp150 for adults with ptsd

Biopharmaceutical company Jazz Pharmaceuticals plc (NASDAQ: JAZZ) announced Thursday that it has enrolled the first patient in its Phase 2 clinical tr...

December 30, 2021, 1:11 pm

Regenxbio: accumulating for the long haul

RGNX announced promising safety and efficacy data from its SCS micro injector trial....

December 26, 2021, 6:48 am

Regenxbio: accumulating for the long haul

RGNX announced promising safety and efficacy data from its SCS micro injector trial....

December 26, 2021, 6:48 am

Regenxbio: accumulating for the long haul

RGNX announced promising safety and efficacy data from its SCS micro injector trial....

December 26, 2021, 6:48 am

Sesen bio to conduct additional trial for potential resubmission of vicineum in bladder cancer

Sesen Bio Inc (NASDAQ: SESN) has outlined its anticipated regulatory path forward for Vicineum for BCG-unresponsive non-muscle invasive bladder can...

December 9, 2021, 1:09 pm

Sesen bio to conduct additional trial for potential resubmission of vicineum in bladder cancer

Sesen Bio Inc (NASDAQ: SESN) has outlined its anticipated regulatory path forward for Vicineum for BCG-unresponsive non-muscle invasive bladder can...

December 9, 2021, 1:09 pm

Sesen bio to conduct additional trial for potential resubmission of vicineum in bladder cancer

Sesen Bio Inc (NASDAQ: SESN) has outlined its anticipated regulatory path forward for Vicineum for BCG-unresponsive non-muscle invasive bladder can...

December 9, 2021, 1:09 pm

cactus, inc. (whd) down 13.2% since last earnings report: can it rebound?

cactus, Inc. (WHD) reported earnings 30 days ago. What's next for the stock?...

December 3, 2021, 1:00 pm

cactus, inc. (whd) down 13.2% since last earnings report: can it rebound?

cactus, Inc. (WHD) reported earnings 30 days ago. What's next for the stock?...

December 3, 2021, 1:00 pm

cactus, inc. (whd) down 13.2% since last earnings report: can it rebound?

cactus, Inc. (WHD) reported earnings 30 days ago. What's next for the stock?...

December 3, 2021, 1:00 pm

Redhill biopharma's talicia for bacterial infections shows efficacy irrespective of patient bmi

RedHill Biopharma Ltd (NASDAQ: RDHL) has announced the publication of a new study of Talicia to treat H. pylori infection....

December 2, 2021, 1:22 pm

Redhill biopharma's talicia for bacterial infections shows efficacy irrespective of patient bmi

RedHill Biopharma Ltd (NASDAQ: RDHL) has announced the publication of a new study of Talicia to treat H. pylori infection....

December 2, 2021, 1:22 pm

Redhill biopharma's talicia for bacterial infections shows efficacy irrespective of patient bmi

RedHill Biopharma Ltd (NASDAQ: RDHL) has announced the publication of a new study of Talicia to treat H. pylori infection....

December 2, 2021, 1:22 pm

Dynamic dividend outlook could make sdog super

In recent weeks, equity income investors were treated to a flurry of encouraging dividend news with more arriving prior to the Thanksgiving holiday in...

November 29, 2021, 1:09 pm

Dynamic dividend outlook could make sdog super

In recent weeks, equity income investors were treated to a flurry of encouraging dividend news with more arriving prior to the Thanksgiving holiday in...

November 29, 2021, 1:09 pm

Dynamic dividend outlook could make sdog super

In recent weeks, equity income investors were treated to a flurry of encouraging dividend news with more arriving prior to the Thanksgiving holiday in...

November 29, 2021, 1:09 pm

Sesen bio: hoping for an easy revalidation of vicineum by 2022

The US FDA published the warning letter on October 27, 2021, just 2 days before CMC Type A meeting with Sesen Bio. The move informed its rejection of ...

November 16, 2021, 9:11 pm

Sesen bio: hoping for an easy revalidation of vicineum by 2022

The US FDA published the warning letter on October 27, 2021, just 2 days before CMC Type A meeting with Sesen Bio. The move informed its rejection of ...

November 16, 2021, 9:11 pm


Search within

Pages Search Results: